For the first time, Stanford researchers have created a protein transporter simulation of sugar molecules across cell membranes, providing insight into the development of neurotransmitter drugs for treatment of psychiatric disorders like depression.
The Interfacial Dewetting and Drainage Optical Platform (i-DDrOP) machine recently developed at Stanford is promising to make contact lenses more comfortable. The i-DDrOP, which enables scientists to closely study the eye’s protective tear film, was described in a report published in the March issue of Investigative Opthalmology and Visual Science.
Stanford researchers have redesigned the hepatitis B virus so that it is invisible to the immune system and can target certain cells without delivering an infectious payload. This report was published in the Proceedings of the National Academy of Sciences, and professor of chemical engineering and bioengineering James Swartz, who led the report, hopes his findings will advance targeted drug delivery.
A new study by Stanford researchers found that there is a serious lack of testing for toxoplasmosis infections in the United States, which causes more infections and complications to occur than in other parts of the world, such as Europe, where screening is more prevalent.